Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

Meelan Bul; Roderick C N Van Den Bergh; Antti Rannikko; Riccardo Valdagni; Tom Pickles; Chris H. Bangma; Monique J. Roobol

doi:10.1016/j.eururo.2011.06.027

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

Meelan Bul, Roderick C N Van Den Bergh, Antti Rannikko, Riccardo Valdagni, Tom Pickles, Chris H. Bangma, Monique J. Roobol

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Active surveillance (AS) protocols for low-risk prostate cancer (PCa) generally include repeat prostate biopsies at predefined follow-up intervals. Objective: To study the outcome of routinely obtained 1-yr repeat biopsies and factors predicting reclassification to higher risk, to contribute to risk stratification for men on AS. Design, setting, and participants: We analysed men with low-risk PCa (clinical stage ≤T2, prostate-specific antigen (PSA) ≤10 ng/ml, PSA density

Original language	English
Pages (from-to)	370-377
Number of pages	8
Journal	European Urology
Volume	61
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2011.06.027
Publication status	Published - Feb 2012

Keywords

Active surveillance
Biopsy
Disease progression
Prostate-specific antigen
Prostatic neoplasms
Reclassification
Risk

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2011.06.027

Cite this

@article{820b800b15eb4d179dcb712125c85526,

title = "Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program",

abstract = "Background: Active surveillance (AS) protocols for low-risk prostate cancer (PCa) generally include repeat prostate biopsies at predefined follow-up intervals. Objective: To study the outcome of routinely obtained 1-yr repeat biopsies and factors predicting reclassification to higher risk, to contribute to risk stratification for men on AS. Design, setting, and participants: We analysed men with low-risk PCa (clinical stage ≤T2, prostate-specific antigen (PSA) ≤10 ng/ml, PSA density ",

keywords = "Active surveillance, Biopsy, Disease progression, Prostate-specific antigen, Prostatic neoplasms, Reclassification, Risk",

author = "Meelan Bul and {Van Den Bergh}, {Roderick C N} and Antti Rannikko and Riccardo Valdagni and Tom Pickles and Bangma, {Chris H.} and Roobol, {Monique J.}",

year = "2012",

month = feb,

doi = "10.1016/j.eururo.2011.06.027",

language = "English",

volume = "61",

pages = "370--377",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

AU - Bul, Meelan

AU - Van Den Bergh, Roderick C N

AU - Rannikko, Antti

AU - Valdagni, Riccardo

AU - Pickles, Tom

AU - Bangma, Chris H.

AU - Roobol, Monique J.

PY - 2012/2

Y1 - 2012/2

N2 - Background: Active surveillance (AS) protocols for low-risk prostate cancer (PCa) generally include repeat prostate biopsies at predefined follow-up intervals. Objective: To study the outcome of routinely obtained 1-yr repeat biopsies and factors predicting reclassification to higher risk, to contribute to risk stratification for men on AS. Design, setting, and participants: We analysed men with low-risk PCa (clinical stage ≤T2, prostate-specific antigen (PSA) ≤10 ng/ml, PSA density

AB - Background: Active surveillance (AS) protocols for low-risk prostate cancer (PCa) generally include repeat prostate biopsies at predefined follow-up intervals. Objective: To study the outcome of routinely obtained 1-yr repeat biopsies and factors predicting reclassification to higher risk, to contribute to risk stratification for men on AS. Design, setting, and participants: We analysed men with low-risk PCa (clinical stage ≤T2, prostate-specific antigen (PSA) ≤10 ng/ml, PSA density

KW - Active surveillance

KW - Biopsy

KW - Disease progression

KW - Prostate-specific antigen

KW - Prostatic neoplasms

KW - Reclassification

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=83955162939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83955162939&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2011.06.027

DO - 10.1016/j.eururo.2011.06.027

M3 - Article

C2 - 21704447

AN - SCOPUS:83955162939

VL - 61

SP - 370

EP - 377

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this